At the news
? NEUTRALIMPACT 5/10 CLUSTER filed Mar 3, 2026 at 18:01 ET
Multiple executives at ANI Pharmaceuticals, including the CEO, CFO, and other senior leaders, engaged in tax-related share withholdings and open-market sales over the past week. The total value of transactions exceeds $2.6 million, with $913,092 in open-market sales and $1.7 million in tax withholding dispositions.
- CEO Nikhil Lalwani surrendered 17,060 shares ($1.26M) for tax withholding.
- CFO Stephen Carey and other SVPs also surrendered shares for tax purposes, totaling $1.7M across four executives.
- Two executives, Christopher Mutz and Krista Davis, conducted open-market sales totaling $913,092.
- All open-market sales occurred at prices between $74.13 and $75.00.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access